NimotuzumabNimotuzumab (h-R3, BIOMAb EGFR, Biocon, India; TheraCIM, CIMYM Biosciences, Canada; Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other… Read from the Drugbox of the Wikipedia article Nimotuzumab, revision 1366294132.

Property

Value

Formula

C6566H10082N1746O2056S40, 147657.62 g/mol

Elimination half-life

183 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.